E-LIB Suche - Ergebnisse für: Xiao-Dong Jiao

1

New clinical trial design in precision medicine: discovery,..:

Duan, Xiao-Peng ; Qin, Bao-Dong ; Jiao, Xiao-Dong...
Signal Transduction and Targeted Therapy. 9 (2024) 1 - p. , 2024

2

Immunotherapy-based regimens for patients with EGFR-mutated..:

Qin, Bao-Dong ; Jiao, Xiao-Dong ; Yuan, Ling-Yan...
Journal for ImmunoTherapy of Cancer. 12 (2024) 4 - p. e008818 , 2024

Link: https://doi.org/10.1136/..

3

Targeted therapy for intractable cancer on the basis of mol..:

Jiao, Xiao-Dong ; Qin, Bao-Dong ; Wang, Zhan...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

4

Prognostic value of tumor mutation burden in patients with ..:

Duan, Xiao-Peng ; Liu, Ke ; Jiao, Xiao-Dong...
Frontiers in Oncology. 12 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

5

Image_1_Targeted therapy for intractable cancer on the basi..:

Xiao-Dong Jiao ; Bao-Dong Qin ; Zhan Wang...
doi:10.3389/fonc.2023.860711.s001. , 2023

Link: https://doi.org/10.3389/..

6

DataSheet_1_Prognostic value of tumor mutation burden in pa..:

Xiao-Peng Duan ; Ke Liu ; Xiao-Dong Jiao...
doi:10.3389/fonc.2022.1007146.s001. , 2023

Link: https://doi.org/10.3389/..

7

Targeted therapy for intractable cancer on the basis of mol..:

Xiao-Dong Jiao ; Bao-Dong Qin ; Zhan Wang...
https://www.frontiersin.org/articles/10.3389/fonc.2023.860711/full. , 2023

Link: https://doi.org/10.3389/..

8

Table_1_Targeted therapy for intractable cancer on the basi..:

Xiao-Dong Jiao ; Bao-Dong Qin ; Zhan Wang...
doi:10.3389/fonc.2023.860711.s002. , 2023

Link: https://doi.org/10.3389/..

9

Table_1_Prognostic value of tumor mutation burden in patien..:

Xiao-Peng Duan ; Ke Liu ; Xiao-Dong Jiao...
doi:10.3389/fonc.2022.1007146.s002. , 2023

Link: https://doi.org/10.3389/..

10

Table_2_Targeted therapy for intractable cancer on the basi..:

Xiao-Dong Jiao ; Bao-Dong Qin ; Zhan Wang...
doi:10.3389/fonc.2023.860711.s003. , 2023

Link: https://doi.org/10.3389/..

11

Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity i..:

Yang, Biaolong ; Deng, Biaolong ; Jiao, Xiao-Dong...
Cellular Oncology. 45 (2022) 6 - p. 1297-1309 , 2022

Link: https://doi.org/10.1007/..

12

Effect of smoking habits on the efficacy of EGFR-TKI plus a..:

Qin, Bao-Dong ; Jiao, Xiao-Dong ; Wang, Yan...
Lung Cancer. 170 (2022) - p. 91-97 , 2022

Link: https://doi.org/10.1016/..

13

Cetuximab and vemurafenib plus FOLFIRI (5-fluorouracil/leuc..:

Wang, Zhan ; Qin, Bao-Dong ; Ye, Chen-Yang...
European Journal of Cancer. 163 (2022) - p. 152-162 , 2022

Link: https://doi.org/10.1016/..

14

Effects of concomitant proton pump inhibitor use on immune ..:

Qin, Bao-Dong ; Jiao, Xiao-Dong ; Zhou, Xin-Cheng...
OncoImmunology. 10 (2021) 1 - p. , 2021

Link: https://doi.org/10.1080/..

15

HER2 Splice Site Mutation c.1899-1G>A as the Potential Acqu..:

Jiao, Xiao-Dong ; Liu, Ke ; Wu, Ying...
The Oncologist. 26 (2021) 9 - p. 717-721 , 2021

Link: https://doi.org/10.1002/..